New hires and promotions in the biopharma and med-tech industries, including: Magnolia, Medicenna, Nxera.

The top 10 biopharma stock gainers and losers for the week.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Encora, Inmune, Novocure, Serac, Teijin.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Aardvark, Alkermes, Avadel, Cellprothera, Celyad, Centessa, Eradivir, I-sens, Lifescan, Natus, Nxera, Onconetix, Realbotix, Seres, Therab.

Clinical updates for biopharma and med tech, including data readouts and publications: Annovis, Biovica, Brainscope, Bridgebio, Caredx, Immunesensor, Mesoblast, Surge.

Biopharma and med-tech companies raising money in public or private financings, including: Berlin Heals, Biorestorative, Entirety, Nektar, Neupulse, Neurent, Xilio.

New hires and promotions in the biopharma and med-tech industries, including: Aardvark, Arvinas, Biogen, Compugen, Etienna, Sanofi, Venturemed.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Biocardia, Biofrontera, Biorestorative, GSK, Immune, Moderna, Outlook, Regenxbio, Takeda, Zoll.